[An experimental study of gemcitabine inducing pancreatic cancer cell apoptosis potentiated by nuclear factor-kappa B P65 siRNA].
Kong
Rui
R
Department of Hepatobiliary Pancreatic Surgery, First Affiliated Hospital of Harbin Medical University, Harbin 150001, China.
Sun
Bei
B
Wang
Shuang-jia
SJ
Pan
Shang-ha
SH
Wang
Gang
G
Chen
Hua
H
Xue
Dong-bo
DB
Jiang
Hong-chi
HC
D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D045744:Cell Line, Tumor; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000494:pharmacology; D006801:Humans; D051379:Mice; D008807:Mice, Inbred BALB C; D010190:Pancreatic Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D034741:RNA, Small Interfering / Q000235:genetics*; D051996:Transcription Factor RelA / Q000235:genetics* / Q000378:metabolism; D014162:Transfection; D023041:Xenograft Model Antitumor Assays; D000093542:Gemcitabine
D034741:RNA, Small Interfering; D051996:Transcription Factor RelA; D003841:Deoxycytidine; D000093542:Gemcitabine